Rho guanine nucleotide exchange factor 12 is a protein that in humans is encoded by the ARHGEF12 gene.[5][6][7] This protein is also called RhoGEF12 or Leukemia-associated Rho guanine nucleotide exchange factor (LARG).
Quick Facts Available structures, PDB ...
Close
Rho guanine nucleotide exchange factor 12 is guanine nucleotide exchange factor (GEF) for the RhoA small GTPase protein. [5] Rho is a small GTPase protein that is inactive when bound to the guanine nucleotide GDP. But when acted on by Rho GEF proteins such as RhoGEF1, this GDP is released and replaced by GTP, leading to the active state of Rho. In this active, GTP-bound conformation, Rho can bind to and activate specific effector proteins and enzymes to regulate cellular functions.[8] In particular, active Rho is a major regulator of the cell actin cytoskeleton.[8]
RhoGEF12 is a member of a group of four RhoGEF proteins known to be activated by G protein coupled receptors coupled to the G12 and G13 heterotrimeric G proteins.[9] The others are ARHGEF1 (also known as p115-RhoGEF), ARHGEF11 (also known as PDZ-RhoGEF) and AKAP13 (also known as ARHGEF13 and Lbc). [10][11] GPCR-regulated RhoGEF12 (and these related GEF proteins) acts as an effector for G12 and G13 G proteins. In addition to being activated by G12 or G13 G proteins, three of these four RhoGEF proteins (ARHGEF1/11/12) also function as RGS family GTPase-activating proteins (GAPs) to increase the rate of GTP hydrolysis of G12/G13 alpha proteins (which are themselves GTPase proteins). This action increases the rate of G protein deactivation, limiting the time during which these RhoGEFs activate Rho.[12]
This protein is observed to form myeloid/lymphoid fusion partner in acute myeloid leukemia.[7]
ARHGEF12 has been shown to interact with:
Thumkeo D, Watanabe S, Narumiya S (October–November 2013). "Physiological roles of Rho and Rho effectors in mammals". European Journal of Cell Biology. 92 (10–11): 303–15. doi:10.1016/j.ejcb.2013.09.002. PMID 24183240.
Hirotani M, Ohoka Y, Yamamoto T, Nirasawa H, Furuyama T, Kogo M, et al. (September 2002). "Interaction of plexin-B1 with PDZ domain-containing Rho guanine nucleotide exchange factors". Biochemical and Biophysical Research Communications. 297 (1): 32–7. doi:10.1016/S0006-291X(02)02122-8. PMID 12220504.
- Fukuhara S, Chikumi H, Gutkind JS (November 2000). "Leukemia-associated Rho guanine nucleotide exchange factor (LARG) links heterotrimeric G proteins of the G(12) family to Rho". FEBS Letters. 485 (2–3): 183–8. Bibcode:2000FEBSL.485..183F. doi:10.1016/S0014-5793(00)02224-9. PMID 11094164. S2CID 7300556.
- Reuther GW, Lambert QT, Booden MA, Wennerberg K, Becknell B, Marcucci G, et al. (July 2001). "Leukemia-associated Rho guanine nucleotide exchange factor, a Dbl family protein found mutated in leukemia, causes transformation by activation of RhoA". The Journal of Biological Chemistry. 276 (29): 27145–51. doi:10.1074/jbc.M103565200. PMID 11373293.
- Taya S, Inagaki N, Sengiku H, Makino H, Iwamatsu A, Urakawa I, et al. (November 2001). "Direct interaction of insulin-like growth factor-1 receptor with leukemia-associated RhoGEF". The Journal of Cell Biology. 155 (5): 809–20. doi:10.1083/jcb.200106139. PMC 2150867. PMID 11724822.
- Chikumi H, Fukuhara S, Gutkind JS (April 2002). "Regulation of G protein-linked guanine nucleotide exchange factors for Rho, PDZ-RhoGEF, and LARG by tyrosine phosphorylation: evidence of a role for focal adhesion kinase". The Journal of Biological Chemistry. 277 (14): 12463–73. doi:10.1074/jbc.M108504200. PMID 11799111.
- Perrot V, Vazquez-Prado J, Gutkind JS (November 2002). "Plexin B regulates Rho through the guanine nucleotide exchange factors leukemia-associated Rho GEF (LARG) and PDZ-RhoGEF". The Journal of Biological Chemistry. 277 (45): 43115–20. doi:10.1074/jbc.M206005200. PMID 12183458.
- Aurandt J, Vikis HG, Gutkind JS, Ahn N, Guan KL (September 2002). "The semaphorin receptor plexin-B1 signals through a direct interaction with the Rho-specific nucleotide exchange factor, LARG". Proceedings of the National Academy of Sciences of the United States of America. 99 (19): 12085–90. Bibcode:2002PNAS...9912085A. doi:10.1073/pnas.142433199. PMC 129402. PMID 12196628.
- Hirotani M, Ohoka Y, Yamamoto T, Nirasawa H, Furuyama T, Kogo M, et al. (September 2002). "Interaction of plexin-B1 with PDZ domain-containing Rho guanine nucleotide exchange factors". Biochemical and Biophysical Research Communications. 297 (1): 32–7. doi:10.1016/S0006-291X(02)02122-8. PMID 12220504.
- Driessens MH, Olivo C, Nagata K, Inagaki M, Collard JG (October 2002). "B plexins activate Rho through PDZ-RhoGEF". FEBS Letters. 529 (2–3): 168–72. Bibcode:2002FEBSL.529..168D. doi:10.1016/S0014-5793(02)03323-9. PMID 12372594. S2CID 26525009.
- Wennerberg K, Ellerbroek SM, Liu RY, Karnoub AE, Burridge K, Der CJ (December 2002). "RhoG signals in parallel with Rac1 and Cdc42". The Journal of Biological Chemistry. 277 (49): 47810–7. doi:10.1074/jbc.M203816200. PMID 12376551.
- Suzuki N, Nakamura S, Mano H, Kozasa T (January 2003). "Galpha 12 activates Rho GTPase through tyrosine-phosphorylated leukemia-associated RhoGEF". Proceedings of the National Academy of Sciences of the United States of America. 100 (2): 733–8. Bibcode:2003PNAS..100..733S. doi:10.1073/pnas.0234057100. PMC 141065. PMID 12515866.
- Chikumi H, Barac A, Behbahani B, Gao Y, Teramoto H, Zheng Y, et al. (January 2004). "Homo- and hetero-oligomerization of PDZ-RhoGEF, LARG and p115RhoGEF by their C-terminal region regulates their in vivo Rho GEF activity and transforming potential". Oncogene. 23 (1): 233–40. doi:10.1038/sj.onc.1207012. PMID 14712228.
- Wang Q, Liu M, Kozasa T, Rothstein JD, Sternweis PC, Neubig RR (July 2004). "Thrombin and lysophosphatidic acid receptors utilize distinct rhoGEFs in prostate cancer cells". The Journal of Biological Chemistry. 279 (28): 28831–4. doi:10.1074/jbc.C400105200. PMID 15143072.
- Kristelly R, Gao G, Tesmer JJ (November 2004). "Structural determinants of RhoA binding and nucleotide exchange in leukemia-associated Rho guanine-nucleotide exchange factor". The Journal of Biological Chemistry. 279 (45): 47352–62. doi:10.1074/jbc.M406056200. PMID 15331592.
- Ballif BA, Villén J, Beausoleil SA, Schwartz D, Gygi SP (November 2004). "Phosphoproteomic analysis of the developing mouse brain". Molecular & Cellular Proteomics. 3 (11): 1093–101. doi:10.1074/mcp.M400085-MCP200. PMID 15345747.
- Okuhira K, Fitzgerald ML, Sarracino DA, Manning JJ, Bell SA, Goss JL, et al. (November 2005). "Purification of ATP-binding cassette transporter A1 and associated binding proteins reveals the importance of beta1-syntrophin in cholesterol efflux". The Journal of Biological Chemistry. 280 (47): 39653–64. doi:10.1074/jbc.M510187200. PMID 16192269.
- Goto M, Muramatsu H, Mihara H, Kurihara T, Esaki N, Omi R, et al. (December 2005). "Crystal structures of Delta1-piperideine-2-carboxylate/Delta1-pyrroline-2-carboxylate reductase belonging to a new family of NAD(P)H-dependent oxidoreductases: conformational change, substrate recognition, and stereochemistry of the reaction". The Journal of Biological Chemistry. 280 (49): 40875–84. doi:10.1074/jbc.M507399200. PMID 16192274.
- Bourguignon LY, Gilad E, Brightman A, Diedrich F, Singleton P (May 2006). "Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells". The Journal of Biological Chemistry. 281 (20): 14026–40. doi:10.1074/jbc.M507734200. PMID 16565089.